The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of short QT syndrome type 3
Cardiovascular Research · 30.04.2024 · 120 (5) · 490-505
DOI: 10.1093/cvr/cvae019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 23.01.2024. Verfasst von Ana I Moreno-Manuel und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029 Madrid, Spain. Hauptthemen laut MEDLINE: Atrial Fibrillation, Disease Models, Animal, Myocytes, Cardiac, Potassium Channels, Inwardly Rectifying. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: La Caixa Banking Foundation, Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional.
Abstract (Originalsprache)
Aims
Short QT syndrome type 3 (SQTS3) is a rare arrhythmogenic disease caused by gain-of-function mutations in KCNJ2, the gene coding the inward rectifier potassium channel Kir2.1. We used a multidisciplinary approach and investigated arrhythmogenic mechanisms in an in-vivo model of de-novo mutation Kir2.1E299V identified in a patient presenting an extremely abbreviated QT interval and paroxysmal atrial fibrillation. Methods and results We used intravenous adeno-associated virus-mediated gene transfer to generate mouse models, and confirmed cardiac-specific expression of Kir2.1WT or Kir2.1E299V. On ECG, the Kir2.1E299V mouse recapitulated the QT interval shortening and the atrial-specific arrhythmia of the patient. The PR interval was also significantly shorter in Kir2.1E299V mice. Patch-clamping showed extremely abbreviated action potentials in both atrial and ventricular Kir2.1E299V cardiomyocytes due to a lack of inward-going rectification and increased IK1 at voltages positive to −80 mV. Relative to Kir2.1WT, atrial Kir2.1E299V cardiomyocytes had a significantly reduced slope conductance at voltages negative to −80 mV. After confirming a higher proportion of heterotetrameric Kir2.x channels containing Kir2.2 subunits in the atria, in-silico 3D simulations predicted an atrial-specific impairment of polyamine block and reduced pore diameter in the Kir2.1E299V-Kir2.2WT channel. In ventricular cardiomyocytes, the mutation increased excitability by shifting INa activation and inactivation in the hyperpolarizing direction, which protected the ventricle against arrhythmia. Moreover, Purkinje myocytes from Kir2.1E299V mice manifested substantially higher INa density than Kir2.1WT, explaining the abbreviation in the PR interval.
Conclusion
The first in-vivo mouse model of cardiac-specific SQTS3 recapitulates the electrophysiological phenotype of a patient with the Kir2.1E299V mutation. Kir2.1E299V eliminates rectification in both cardiac chambers but protects against ventricular arrhythmias by increasing excitability in both Purkinje-fiber network and ventricles. Consequently, the predominant arrhythmias are supraventricular likely due to the lack of inward rectification and atrial-specific reduced pore diameter of the Kir2.1E299V-Kir2.2WT heterotetramer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029 Madrid, Spain.
- CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
- Department of Cardiology, Hospital Universitario Virgen de las Nieves, 18014 Granada, Spain.
- Departments of Internal Medicine and Molecular and Integrative Physiology, Center for Arrhythmia Research, University of Michigan, Ann Arbor, MI 4810, USA.
ORCID-Profile: Ana I Moreno-Manuel, Álvaro Macías, Francisco M Cruz, Juan A Bernal, José Jalife
Förderung
- La Caixa Banking Foundation
- Instituto de Salud Carlos III
- Fondo Europeo de Desarrollo Regional
- Fundación La Marató de TV3
- European Union's Horizon 2020 Research and Innovation Programme
- Dynamic Microscopy and Imaging Unit-ICTS-ReDib
- Ministerio de Ciencia e Innovación
- Pro CNIC Foundation
Zitieren
APA
Moreno-Manuel, A. I., Macías, Á., Cruz, F. M., Gutiérrez, L. K., Martínez, F., González-Guerra, A., Martínez Carrascoso, I., Bermúdez-Jimenez, F. J., Sánchez-Pérez, P., Vera-Pedrosa, M. L., Ruiz-Robles, J. M., Bernal, J. A., & Jalife, J. (2024). The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of short QT syndrome type 3. Cardiovascular Research, 120(5), 490-505. https://doi.org/10.1093/cvr/cvae019
Vancouver
Moreno-Manuel AI, Macías Á, Cruz FM, Gutiérrez LK, Martínez F, González-Guerra A, et al. The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of short QT syndrome type 3. Cardiovascular Research. 2024;120(5):490-505. doi:10.1093/cvr/cvae019
BibTeX
@article{MorenoManuel2024,
author = {Moreno-Manuel, Ana I and Macías, Álvaro and Cruz, Francisco M and Gutiérrez, Lilian K and Martínez, Fernando and González-Guerra, Andrés and Martínez Carrascoso, Isabel and Bermúdez-Jimenez, Francisco José and Sánchez-Pérez, Patricia and Vera-Pedrosa, María Linarejos and Ruiz-Robles, Juan Manuel and Bernal, Juan A and Jalife, José},
title = {The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of short QT syndrome type 3},
journal = {Cardiovascular Research},
year = {2024},
volume = {120},
number = {5},
pages = {490--505},
doi = {10.1093/cvr/cvae019}
}
EUVIMED